We then examined the surface expression levels of IL-17RA and IL-17RC on two CTL subsets of tumor-infiltrated lymphocytes (TILs) based on the surface markers of Slamf6 and Tim3 [21]. The gene discussed is SLAMF6; the disease is neoplasm.